2024 Addiction Medicine Board Exam Preparation Course
The Addiction Medicine Board Exam Preparation Workshop is designed for those preparing to take the American Board of Preventive Medicine (ABPM) Addiction Medicine Board Exam and is aligned with the Board’s exam content Blueprint. The faculty of experienced educators will cover 16 key topic areas, with sample exam questions and rationale provided for answers. Test-taking and study tips will be covered. Registration for the all-day workshop includes access to the online High Yield Question Bank after the conclusion of the conference.
PRICE: $495 (Members) | $699 (Non-Members)
Target Audience
- Those planning on taking the ABPM Addiction Medicine Board Exam.
- Physicians and other clinicians who wish to conduct a self assessment of their knowledge of addiction medicine in order to identify areas for further study.
Learning Objectives
This course is designed to assist learners in assessing their competence in subject areas that comprise addiction medicine, and plan further study as needed.
- Navigating Pain Management: Soraya Azari, MD | Joan Deng, MD, PhD Caitlin Garvey, RN, MS, AGPCNP-bc
- Train the Trainer: Develop and Implement a Destigmatization Workshop for Your Clinical and Administrative Staff | Jesse Ristau, MD | Irina (Era) Kryzhanovskaya, MD | Debora Ghosh
- Shifting Paradigms: Navigating Psychedelic Therapy in Mental Health and Addiction | Eva Altobelli, MD | Steve Rosonke, MD | Veronika Gold, MA, LMFT | Ivy Rose Marsh, LCSW Yeshiva Blakeney | Amy de la Garza, MD, FASAM, IFMCP
- Motivational Interviewing for Busy Clinicians and Educators | Matt Tierney, MD | Jennifer Hettema, PhD
- Harm Reduction | Maia Szalavitz | Moderated by Chwen-Yuen Angie Chen, MD, FACP, FASAM
- Neurobiology of Addiction Redefined: Social Determinants on Genetic Vulnerability | George Koob, PhD
- Opioids: Long-acting Buprenorphine and Overdose Prevention of Unhoused Fentanyl Era: A Street Medicine Approach | Christy Soran, MD, MPH | Trevor Lee, MD
- Ever Present Danger of "Corporate Capture" Related to Decriminalized Drugs | Benjamin Breen, PhD
- Restructuring Addiction Care Access in Carceral Population and System | Shira Shavit, MD | Jon Watson, MD | Judge Michael Isaku Begert
- Women and Addiction Team Lily | Rebecca Schwartz, MSW | Dana Lazarovitz, PHN | Teresa Rondone, Navigator | Caitlin Felden-Heimer, MD
- SUD in Transgender and Nonbinary Individuals | Jackie Alba-Nguyen, MD, MPH
- Youth and Substance Use | Veronika Mesheriakova, MD
- Harm Reduction for Youth: Just Say Know | Chelsea L. Shover PhD
- Stimulants: Statewide Roll-Out of Contingency Management Programs for Stimulant Use
- Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illicit Use | Brian Hurley, MD, MBA, FAPA, DFASAM
- Smoking Cessation Intervention in Homeless and Marginally Housed Persons | Maya Vijayaraghavan, MD, MAS
- Cannabis and Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD
- Broadening the Scope: Should Methadone Remain Siloed to OTPs? | Scott Steiger, MD | Hillary Kunis, MD
Chwen-Yuen Angie Chen, MD, FACP, FASAM, Co-Chair
Dr. Chen is a Board Certified Internist and Addiction Medicine Specialist. She is a Clinical Associate Professor of Medicine at Stanford University School of Medicine and is Medical Director of the Primary Care Chemical Dependency Clinics, teaching medical students, residents and fellows. She is on the CSAM Board of Directors as Chair of Communications and Editor of CSAM News.
No relevant financial relationships to disclose.
Daniel Cox, MD
Dr. Cox graduated from UCSF School of Medicine, AOA distinction. He worked for one year in the homeless primary care, focused on Addiction Medicine, "Skid Row" (4th and San Pedro), LA. He is attending, VCMC Addiction Medicine Fellowship and Consult Service. He is board certified in Addiction Medicine.
No relevant financial relationships to disclose.
Amy de la Garza, MD
I am a family practice physician who has dedicated a large part of my training and professional practice to the care of patients with substance use disorder (SUD). I completed my Addiction Medicine Fellowship at the University of Utah and became ABPM board certified in January of this year. I am also a certified practitioner throught the Institute for Functional Medicine. In 2017 I founded Heron Wellness and began my journey caring for individuals with behavioral health diagnoses, including SUD, with an integrative behavioral health approach. I work with patients to address their nutrition, sleep, movement, stress management and healthy social connections as well as addressing hormonal imbalance as indicated. I utilize a group medical visit model to address isolation and lonliness and am working to expand the group model for ketamine assisted psychotherapy for SUD. I spent 2021-2022 working with a psychedelic medicine research organization where I received training in the administration of ketamine for the treatment of depression, psilocybin for major depression clinical research, and ketamine and Mindfulness Oriented Recovery Enhancement for OUD.
No relevant financial relationships to disclose.
Dorothy DeGuzman (she/her/hers), MD/MPH
Currently Associate Program Director at Ventura County Medical Center and faculty of our Primary Care Addiction Medicine Fellowship. I obtained my x-waiver as a resident in 2010, it has been my honor to treat patients with substance use disorder since then.
No relevant financial relationships to disclose.
Dustin DeYoung, MD
Dr. DeYoung is a psychiatrist for the University of California, Los Angeles (UCLA) Behavioral Health Associates. He received his medical degree from the University of Michigan Medical School and completed a combined residency in Psychiatry and Family Medicine at the University of Iowa Hospitals and Clinics. He then completed a NIDA-sponsored T32 Training Program on Addiction Medicine at UCLA and previously worked as a research physician for the UCLA Department of Family Medicine. He is board certified in Psychiatry, Family Medicine, and Addiction Medicine. He has a busy general psychiatry practice, has worked on multiple NIH-funded clinical trials evaluating different medications for the treatment of methamphetamine use disorders, and has co-founded a company to explore therapeutic options for chronic pain and opioid use disorders. He is most interested in the integration of mental health and addiction services, chronic pain and opioid use disorder, and the benefits and risks of cannabis.
Disclosure: BDH Pharma, LLC - Salary as Co-Founder
Waseem Khader, DO
Waseem Khader, DO, FASAM is an Addiction and Family Physician serving San Diego, Riverside, and San Bernardino counties. He is the Clinic Medical Director of Revive Pathway, an opioid treatment program based in El Cajon which provides whole person care encompassing primary care, infectious disease, and mental health needs. He is an Assistant Professor of Addiction Medicine in the Department of Preventive Medicine at Loma Linda University. He also serves as clinical faculty and Karma Doctors and Global Medical Detox. Waseem is a healthcare professional devoted to patient care. He is passionate about preventive whole-person care and treatment of individuals in our society suffering with substance use disorders. In his free time, he enjoys reading, exercising, and spending time with his family.
No relevant financial relationships to disclose.
Thomas W. Meeks, MD, FASAM, Co-Chair
Dr. Meeks completed psychiatry training at Emory University in Atlanta then a geriatric psychiatry fellowship at UC San Diego. Later he began working for the San Diego VA in their addiction treatment program and obtained certification in addiction medicine. He is currently Medical Director for the Portland VA Health Care System's Substance Addiction Treatment Program and Opioid Treatment Program. He is an Assistant Professor of Psychiatry at Oregon Health & Science University where he is a VA Site Director for the OHSU Addiction Medicine Fellowship and Associate Program Director for the OHSU Addiction Psychiatry Fellowship.
No relevant financial relationships to disclose.
Isabella Morton, MD, MPH
Dr. Morton completed her psychiatry fellowship at UCLA and Addiction Psychiatry Fellowship at UCSF. Throughout her training she worked with individuals with severe mental illness, homelessness and criminal legal involvement. She now works at the Greater Los Angeles VA in the SUD clinic, psychosis clinic, and doing street outreach.
No relevant financial relationships to disclose.
Katherine Pier, MD
Dr. Pier practices Addiction and General Psychiatry at Kaiser Permanente. She is originally from New York City and completed medical school and residency at Mount Sinai Hospital before moving with her family on a leap of faith out West to continue her training with UCSF's Addiction Psychiatry Fellowship. She was able to join as faculty at one of the best rotations of the fellowship, which takes place in the Addiction Medicine Recovery Services at Kaiser in San Francisco. She is a voluntary Assistant Clinical Professor at UCSF and is now Kaiser's Site Director for the fellowship. Kate is married to her high school crush. They have two daughters, Sarah & Anna, ages 5 and 2. Kate loves animals, crafts, baking, on-demand workouts, love stories, party favors, and pizza, especially pepperoni mushroom.
No relevant financial relationships to disclose.
Eleasa Sokolski, MD
Dr. Sokolski recently completed her Addiction Medicine fellowship at Oregon Health & Science University (OHSU) in July 2022 and is joining the OHSU faculty this summer as an Assistant Professor. She will be providing inpatient Addiction Medicine consultation as part of the Improving Addiction Care Team at both the OHSU main hospital and Hillsboro Medical Center. Additionally, she will be providing outpatient psychiatry consultation for the internal medicine clinic. She is originally from California and attended both college and medical school at UC San Diego followed by a combined Internal Medicine and Psychiatry Residency at UC Davis. Dr. Sokolski's professional interests include medical education, treatment of co-occurring addiction and psychiatric disorders, and the application of psychotherapy interventions to the hospital setting. In her free time, she enjoys spending time in nature by hiking and rock climbing.
No relevant financial relationships to disclose.
Takeo Toyoshima, MD, MRO
Dr. Toyoshima is a general, addiction, and forensic psychiatrist based out of the San Francisco Bay Area. He is triple boarded-certified in psychiatry, addiction psychiatry, and forensic psychiatry. He completed his undergraduate studies at Yale, medical school at UCLA, then psychiatry residency, addiction psychiatry fellowship, and forensic psychiatry fellowship at UCSF. He currently serves as the medical director of the Drug and Alcohol Treatment Clinic at the San Francisco VA Medical Center. He is an assistant professor of psychiatry at UCSF, serves as the VA Site Director for the UCSF Addiction Psychiatry Fellowship, and operates a private clinical and forensic practice. His areas of interest include addiction and dual diagnosis including those with serious mental illness; forensics; Japanese and Asian-American mental health; and financial health/literacy's relationship with mental health. He is fluent in Japanese and is one of the only Japanese-speaking psychiatrists on the west coast of the United States.
Disclosure: Roche (Ended as of 07/2021) - Consultant; Intuitive Surgical - Stocks
Mason Turner, MD, FASAM
Dr. Turner is the Senior Medical Director for Behavioral Health for Intermountain Healthcare based in Salt Lake City, UT. His leadership in mental health care focuses on the development and evolution of strategic innovations in behavioral health care delivery that enhance quality of care and clinical excellence and are guided by principles of equity and inclusion of the patient/consumer voice into all aspects of the behavioral healthcare ecosystem. Including integration initiatives which link mental health care and addiction medicine services with both primary and specialty medical care, as well as supporting innovative technological means of reaching patients for treatment of behavioral health conditions, he is also committed to enhancing access for behavioral health care services to all those who need it. Additionally, he has extensive experience in promoting employee health and well-being in a variety of corporate and healthcare sectors. As a clinician, he specializes in addiction medicine, consult-liaison psychiatry and treatment of personality disorders. He has received extensive training in resiliency-and systems-based approaches for improving the mental health and well-being of refugees, asylum seekers and torture survivors. Dr. Turner also served as a former Assistant Clinical Professor in Psychiatry at the University of California, San Francisco Medical School, where he taught medical students at all levels the practice of interviewing patients and clinical reasoning skills. He also served as adjunct faculty at the University of Hawaii John A. Burns School of Medicine.
No relevant financial relationships to disclose.
Zachary Zwolak, DO, FAAFP, FASAM
Dr. Zwolak received his Osteopathic Medical Degree from the Lake Erie College of Osteopathic Medicine in Erie, PA. He then completed his Family Medicine Residency training at St. Luke's University Health Network, Bethelem, PA. He went on to complete a High Risk Obstetrics Fellowship at Natividad Medical Center in Salinas, CA. He joined the Family Medicine Faculty at Ventura County Medical Center in 2014, later advancing to Associate Program Director. He became Addiction Medicine Board Certified 2 years ago following completion of the Addiction Medicine Practice Pathway. He assisted with the formation of the Primary Care Addiction Medicine Fellowship at VCMC and continues as faculty. Dr. Zwolak has practiced addiction medicine at several residential treatment centers in Ventura County. He is passionate for teaching addiction medicine, caring for pregnant women using substances and the underserved suffering with addiction.
No relevant financial relationships to disclose.
CREDIT
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this enduring material for a maximum of 7 AMA/PRA Category 1 Credits™. (Physicians should only claim credit commensurate with the extent of their participation in the activity.) This credit may also be applied to the CMA Certification in Continuing Medical Education.
NON-PHYSICIANS: The California Society of Addiction Medicine (CSAM) provides a certificate of attendance for this online course based upon the number of hours you participated, up to maximum of 7.
Available Credit
- 7.00 AMA Category 1
- 7.00 Attendance